For the quarter ending 2026-03-31, TNDM had $88,691K increase in cash & cash equivalents over the period. $4,786K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on extinguishment of debt | - | 0 | 0 | 0 |
| Net loss | -20,393 | -589 | -21,165 | -182,956 |
| Depreciation and amortization expense | 4,504 | 4,495 | 4,493 | 8,678 |
| Amortization of debt issuance costs | 576 | 446 | 444 | 970 |
| Provision for expected credit losses | 2,109 | 2,733 | 3,168 | 3,577 |
| Operating lease and other impairment charges | 0 | 0 | 0 | 6,697 |
| Amortization of discount or (accretion of premium) on short-term investments | 747 | 1,745 | 303 | 1,780 |
| Loss from equity method investments | -3,865 | -4,553 | -2,724 | -6,917 |
| Stock-based compensation expense | 15,660 | 20,110 | 21,141 | 51,130 |
| Acquired in-process research and development expenses | 0 | 0 | 0 | 75,217 |
| Other | 1,804 | 3,322 | 617 | 424 |
| Accounts receivable, net | -22,680 | 42,014 | 1,282 | 13,516 |
| Inventories | -1,927 | -7,564 | -5,194 | -12,058 |
| Prepaid and other current assets | 18,997 | -3,052 | 9,792 | 2,348 |
| Other long-term assets | 8,521 | 10,473 | -61 | -3,524 |
| Accounts payable | 13,754 | 5,818 | -9,330 | 5,739 |
| Accrued expenses | - | -664 | - | - |
| Employee-related liabilities | -14,743 | 5,798 | 12,846 | -12,649 |
| Deferred revenue | -1,078 | -686 | -1,392 | -2,710 |
| Operating leases and other current liabilities | 7,892 | 10,208 | 614 | 8,403 |
| Other long-term liabilities | 762 | -2,139 | 226 | 4,851 |
| Net cash provided by (used in) operating activities | 11,054 | 9,789 | 8,264 | -27,774 |
| Purchases of short-term investments | 216,130 | 29,656 | 29,508 | 26,496 |
| Proceeds from maturities and redemptions of short-term investments | 26,950 | 56,489 | 54,136 | 146,447 |
| Purchases of property and equipment | 6,268 | 6,685 | 4,092 | 9,171 |
| Acquisition of in-process research and development | 0 | 35,124 | 0 | 43,464 |
| Purchases of equity investments, strategic investments, and intangible assets | - | 0 | - | - |
| Net cash provided by (used in) investing activities | -195,448 | -14,976 | 20,536 | 67,316 |
| Principal payments on convertible senior notes due 2025 | - | 0 | 0 | 40,760 |
| Repurchase and retirement of common stock | - | 0 | 0 | 0 |
| Repurchase of 246,740 principal amount of convertible senior notes due 2025 | - | 0 | 0 | 0 |
| Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under company stock plans | - | - | 1,570 | 3,641 |
| Other financing activities | - | 0 | 0 | 0 |
| Proceeds from issuance of convertible senior notes due 2032, net of 8,843 debt issuance costs | 291,157 | 0 | 0 | 0 |
| Payment for capped call transactions related to convertible senior notes due 2032 | 15,300 | 0 | 0 | 0 |
| Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under company stock plans | 1,696 | 2,607 | - | - |
| Net cash provided by (used in) financing activities | 274,161 | 2,604 | -1,570 | -44,401 |
| Effect of foreign exchange rate changes on cash | -1,076 | 1,270 | 605 | -263 |
| Net increase (decrease) in cash and cash equivalents | 88,691 | -1,313 | 27,835 | -5,122 |
| Cash and cash equivalents at beginning of period | 90,634 | 91,947 | 69,234 | - |
| Cash and cash equivalents at end of period | 179,325 | 90,634 | 91,947 | - |